Literature DB >> 29531619

Follow-up in community pharmacy should be routine, not extraordinary.

Lori MacCallum1,2,3, Lisa Dolovich1,2,3.   

Abstract

Year:  2018        PMID: 29531619      PMCID: PMC5843118          DOI: 10.1177/1715163518756586

Source DB:  PubMed          Journal:  Can Pharm J (Ott)        ISSN: 1715-1635


× No keyword cloud information.
  11 in total

Review 1.  Continuity of care in medication management: review of issues and considerations for pharmacy.

Authors: 
Journal:  Am J Health Syst Pharm       Date:  2005-08-15       Impact factor: 2.637

2.  The Effectiveness of Pharmacist Interventions on Cardiovascular Risk: The Multicenter Randomized Controlled RxEACH Trial.

Authors:  Ross T Tsuyuki; Yazid N Al Hamarneh; Charlotte A Jones; Brenda R Hemmelgarn
Journal:  J Am Coll Cardiol       Date:  2016-04-04       Impact factor: 24.094

3.  Part 1: Barriers to the advancement of the pharmacy profession.

Authors:  Jonathan Penm; Derek Jorgenson; Neil J MacKinnon; Jennifer Smith
Journal:  Can Pharm J (Ott)       Date:  2017-04-07

4.  Uptake of the MedsCheck annual medication review service in Ontario community pharmacies between 2007 and 2013.

Authors:  Lisa Dolovich; Giulia Consiglio; Linda MacKeigan; Lusine Abrahamyan; Petros Pechlivanoglou; Valeria E Rac; Nedzad Pojskic; Elizabeth A Bojarski; Jiandong Su; Murray Krahn; Suzanne M Cadarette
Journal:  Can Pharm J (Ott)       Date:  2016-08-09

5.  A qualitative assessment of West Virginia pharmacist activities and attitude in diabetes management.

Authors:  Aymen Shatnawi; David A Latif
Journal:  J Eval Clin Pract       Date:  2016-11-24       Impact factor: 2.431

6.  Implementation of a reimbursed medication review program: Corporate and pharmacy level strategies.

Authors:  Linda D MacKeigan; Nadine Ijaz; Elizabeth A Bojarski; Lisa Dolovich
Journal:  Res Social Adm Pharm       Date:  2017-03-31

7.  A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN).

Authors:  Donna L McLean; Finlay A McAlister; Jeffery A Johnson; Kathryn M King; Mark J Makowsky; Charlotte A Jones; Ross T Tsuyuki
Journal:  Arch Intern Med       Date:  2008-11-24

8.  After the diabetes care trial ends, now what? A 1-year follow-up of the RxING study.

Authors:  Yazid N Al Hamarneh; Luc Sauriol; Ross T Tsuyuki
Journal:  BMJ Open       Date:  2015-08-12       Impact factor: 2.692

9.  Pharmacist Interventions in the Management of Type 2 Diabetes Mellitus: A Systematic Review of Randomized Controlled Trials.

Authors:  Sarah Pousinho; Manuel Morgado; Amílcar Falcão; Gilberto Alves
Journal:  J Manag Care Spec Pharm       Date:  2016-05

10.  Pharmacist intervention for glycaemic control in the community (the RxING study).

Authors:  Yazid N Al Hamarneh; Theresa Charrois; Richard Lewanczuk; Ross T Tsuyuki
Journal:  BMJ Open       Date:  2013-09-24       Impact factor: 2.692

View more
  4 in total

1.  Is it time for internal medicine pharmacists in primary care?

Authors:  Derek Jorgenson
Journal:  Can Pharm J (Ott)       Date:  2018-06-01

2.  What do persons with diabetes want from community pharmacies? A qualitative study.

Authors:  Gitte Reventlov Husted; Rikke Nørgaard Hansen; Mira El-Souri; Janne Kunchel Lorenzen; Peter Bindslev Iversen; Charlotte Verner Rossing
Journal:  Pharm Pract (Granada)       Date:  2022-06-17

3.  Clinical pharmacists´ interventions in the management of type 2 diabetes mellitus: a systematic review.

Authors:  Sarah Pousinho; Manuel Morgado; Ana I Plácido; Fátima Roque; Amílcar Falcão; Gilberto Alves
Journal:  Pharm Pract (Granada)       Date:  2020-08-28

4.  Impact of the 2016 Policy Change on the Delivery of MedsCheck Services in Ontario: An Interrupted Time-Series Analysis.

Authors:  Ahmad Shakeri; Lisa Dolovich; Lori MacCallum; John-Michael Gamble; Limei Zhou; Suzanne M Cadarette
Journal:  Pharmacy (Basel)       Date:  2019-08-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.